Why ‘Established Conditions’ CMC Approach Could Generate More Supporting Information, Not Less

The ‘established conditions’ concept enshrined in the ICH Q12 draft guideline was the US FDA’s answer to the background information that has cluttered new drug applications in the quality-by-design era. But early indications are that it will amass information clutter of its own.